POCI
NASDAQPrecision Optics Corporation Inc.
SectorHealth CareIndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
News25/Ratings0
News · 26 weeks26-83%
2025-12-282026-06-21
Mix1790d
- Insider6(35%)
- SEC Filings4(24%)
- Offering3(18%)
- Other3(18%)
- Earnings1(6%)
Latest news
25 items- PRPrecision Optics to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026LITTLETON, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it will be presenting at the Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub on Wednesday, June 17, 2026, at 11:00 a.m. Pacific time at the Bellagio Resort & Hotel. To access the live webcast, please use the following information: Planet MicroCap Las Vegas 2026 Investor Conference Powered by MicroCapClub Date: Wednesday, June 17, 2026 Time: 11:00 a.m. Pacific time Webcast: https://event.summitcast.com/view
- PRPrecision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026LITTLETON, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026. Company WebcastThe webcast presentation will take place at 1:00 p.m. ET on Thursday, May 28, 2026. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2026/ or directly at https://app.webinar.net/Ka2bMmgyojv. The webcast
- PRPrecision Optics Reports Third Quarter Fiscal Year 2026 Financial ResultsLITTLETON, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an unaudited basis for its third quarter fiscal year 2026 for the period ended March 31, 2026. Q3 2026 Financial Highlights (3 Months Ended March 31, 2026): Revenue was $8.7 million, a quarterly record, compared to $4.2 million in the same quarter of the previous fiscal year, representing growth of approximately 108%, and compared to $7.4 million in the most recent sequential quarter.Production revenue, or total revenue net of engineering rev
- SECSEC Form 10-Q filed by Precision Optics Corporation Inc.10-Q - PRECISION OPTICS CORPORATION, INC. (0000867840) (Filer)
- INSIDERNew insider Needham Investment Management Llc claimed ownership of 3,341,100 shares (SEC Form 3)3 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)
- PRPrecision Optics Schedules Third Quarter of Fiscal Year 2026 Conference Call for May 13, 2026LITTLETON, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company's third quarter fiscal year 2026 financial results on Wednesday, May 13, 2026, at 5:00 p.m. ET. The Company intends to release its financial results and to file its 10-Q after the close of the market on Wednesday, May 13, 2026, followed by the conference call. Conference Call Details Date and Time: Wednesday, May 13, 2026, at 5:00 p.m. ET. Call-in Information: Interested partie
- PRPrecision Optics Announces Receipt of $3.5 Million Follow-On Production Order for Single-Use Ophthalmic ProgramLITTLETON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced the receipt of a follow-on production order totaling approximately $3.5 million from a large, global medical device company for a new single-use ophthalmic endoscope. The single-use ophthalmic program is Precision Optics' second single-use program to move into production, further highlighting the Company's growth opportunity in single-use endoscopy. Shipments under the order are expected to commence shortly and be fulfilled over the following 12 to 15 months
- INSIDERSEC Form 3 filed by new insider Needham Investment Management Llc3 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)
- INSIDERSEC Form 4 filed by Coll Wayne M4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)
- INSIDERSEC Form 4 filed by Traut Joseph4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)
- INSIDERSEC Form 4 filed by Forkey Joseph Norman4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)
- INSIDERSEC Form 4 filed by Coll Wayne M4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)
- SECPrecision Optics Corporation Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - PRECISION OPTICS CORPORATION, INC. (0000867840) (Filer)
- SECSEC Form 424B5 filed by Precision Optics Corporation Inc.424B5 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Filer)
- PRPrecision Optics Corporation, Inc. Announces Pricing of Upsized $10 Million Public Offering of Common StockGARDNER, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced the pricing of its previously announced underwritten public offering of 2,777,777 shares of its common stock at a public offering price of $3.60 per share, before deducting underwriting discounts and commissions and offering expenses. The oversubscribed offering was led by a mix of existing and new fundamental institutional investors and included participation from directors, officers and executive management of the company including Dr. Joseph N. Forkey, th
- SECSEC Form 424B5 filed by Precision Optics Corporation Inc.424B5 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Filer)
- PRPrecision Optics Corporation, Inc. Announces Proposed Public Offering of Common StockGARDNER, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it is commencing an underwritten public offering of shares of its common stock (or common stock equivalents). The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Lucid Capital Markets is acting as the sole book-running manager for the offering. The offering is being made pursuant to a shelf registration statement on Form S-3 (
- SECPrecision Optics Corporation Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - PRECISION OPTICS CORPORATION, INC. (0000867840) (Filer)
- INSIDERDirector Miclot Andrew J. exercised 20,000 shares at a strike of $1.44 and covered exercise/tax liability with 6,372 shares (SEC Form 4)4 - PRECISION OPTICS CORPORATION, INC. (0000867840) (Issuer)
- PRPrecision Optics Reports Second Quarter Fiscal Year 2026 Financial ResultsGARDNER, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, announced operating results on an unaudited basis for its second quarter fiscal year 2026 for the period ended December 31, 2025. Q2 2026 Financial Highlights (3 Months Ended December 31, 2025): Revenue was $7.4 million, a quarterly record, compared to $4.5 million in the same quarter of the previous fiscal year, representing growth of approximately 63%, and compared to $6.7 million in the most recent sequential quarter.Production revenue was $6.4 million, a quarterly recor
- SECSEC Form 10-Q filed by Precision Optics Corporation Inc.10-Q - PRECISION OPTICS CORPORATION, INC. (0000867840) (Filer)
- PRPrecision Optics Schedules Second Quarter of Fiscal Year 2026 Conference Call for February 17, 2026GARDNER, Mass., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ:POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company's second quarter fiscal year 2026 financial results on Tuesday, February 17, 2026, at 5:00 p.m. ET. The Company intends to release its financial results and to file its 10-Q after the close of the market on Tuesday, February 17, 2026, followed by the conference call. Conference Call Details Date and Time: Tuesday, February 17, 2026, at 5:00 p.m. ET. Call-in Information: Interest
- SECSEC Form DEFR14A filed by Precision Optics Corporation Inc.DEFR14A - PRECISION OPTICS CORPORATION, INC. (0000867840) (Filer)
- SECSEC Form DEFA14A filed by Precision Optics Corporation Inc.DEFA14A - PRECISION OPTICS CORPORATION, INC. (0000867840) (Filer)
- SECSEC Form DEF 14A filed by Precision Optics Corporation Inc.DEF 14A - PRECISION OPTICS CORPORATION, INC. (0000867840) (Filer)
POCI FAQ
4 questionsWhere does POCI stock trade?
Precision Optics Corporation Inc. (POCI) is listed on NASDAQ.What sector and industry is POCI in?
Precision Optics Corporation Inc. operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.What companies are similar to POCI?
Notable peers in the same industry include MDT (Medtronic plc.), MASI (Masimo Corporation), SEAS (SeaWorld Entertainment Inc.), LIVN (LivaNova PLC), ITGR (Integer Holdings Corporation). Compare POCI side-by-side with any of them on Quantisnow.How can I track POCI on Quantisnow?
Quantisnow aggregates Precision Optics Corporation Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow POCI to receive live email and push alerts on every new disclosure.